Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750944
Max Phase: Preclinical
Molecular Formula: C23H39NO2
Molecular Weight: 361.57
Molecule Type: Unknown
Associated Items:
ID: ALA4750944
Max Phase: Preclinical
Molecular Formula: C23H39NO2
Molecular Weight: 361.57
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1
Standard InChI: InChI=1S/C23H39NO2/c1-2-3-4-5-6-7-8-19-9-11-22-16-20(10-12-21(22)15-19)13-14-23(24,17-25)18-26/h10,12,16,19,25-26H,2-9,11,13-15,17-18,24H2,1H3
Standard InChI Key: SQKXCOAPPIICFR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 361.57 | Molecular Weight (Monoisotopic): 361.2981 | AlogP: 4.16 | #Rotatable Bonds: 12 |
Polar Surface Area: 66.48 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.38 | CX LogP: 5.29 | CX LogD: 3.34 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.49 | Np Likeness Score: 0.83 |
1. Yang MG,Xiao Z,Dhar TG,Xiao HY,Gilmore JL,Marcoux D,Xie JH,McIntyre KW,Taylor TL,Borowski V,Heimrich E,Li YW,Feng J,Fernandes A,Yang Z,Balimane P,Marino AM,Cornelius G,Warrack BM,Mathur A,Wu DR,Li P,Gupta A,Pragalathan B,Shen DR,Cvijic ME,Lehman-McKeeman LD,Salter-Cid L,Barrish JC,Carter PH,Dyckman AJ. (2016) Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P Receptor Modulator., 59 (24.0): [PMID:28002964] [10.1021/acs.jmedchem.6b01433] |
Source(1):